2023
DOI: 10.1002/prot.26509
|View full text |Cite
|
Sign up to set email alerts
|

Cross‐linking disulfide bonds govern solution structures of diabodies

Abstract: In the last years, antibodies have emerged as a promising new class of therapeutics, due to their combination of high specificity with long serum half‐life and low risk of side‐effects. Diabodies are a popular novel antibody format, consisting of two Fv domains connected with short linkers. Like IgG antibodies, they simultaneously bind two target proteins. However, they offer altered properties, given their smaller size and higher rigidity. In this study, we conducted the—to our knowledge—first molecular dynam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 102 publications
(232 reference statements)
0
1
0
Order By: Relevance
“…This linker is too short to allow mispairings of the two Fvs, and, therefore, the domains form two binding sites [ 192 ]. The two sites of a diabody can be either identical, resulting in a monospecific biologic, or distinct, resulting in bispecificity [ 193 , 194 ].…”
Section: Antibody Engineering—design Of Special Formats/interface Cha...mentioning
confidence: 99%
“…This linker is too short to allow mispairings of the two Fvs, and, therefore, the domains form two binding sites [ 192 ]. The two sites of a diabody can be either identical, resulting in a monospecific biologic, or distinct, resulting in bispecificity [ 193 , 194 ].…”
Section: Antibody Engineering—design Of Special Formats/interface Cha...mentioning
confidence: 99%